Point-Of-Care Diagnostic Market worth $27.5 Billion by 2018 The report “Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and the Rest of the World. Browse 198 market data tables and 48 figures spread through 452 pages and in-depth TOC on “Point-Of-Care Diagnostic Market”. http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html Early buyers will receive 10% customization on reports. This report studies the global POC diagnostics market over the forecast period of 2013 to 2018. The market is poised to grow at a CAGR of 9.3% from 2013 to 2018, to reach $27.5 billion by 2018. The global Point-Of-Care Diagnostics market is broadly categorized into infectious diseases testing kits, glucose monitoring kits, coagulation monitoring kits, urinalysis testing kits, hematology testing kits, cholesterol test strips, drugs of abuse testing kits, cardiac markers, blood gas/electrolytes testing kits, tumor/cancer markers, pregnancy and fertility testing kits, fecal occult testing kits, food pathogens testing kits, and others. The glucose monitoring kits segment accounted for the largest share of the market in 2013, while cardiac markers segment is expected to grow at the highest CAGR in the forecast period. Download Free PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=106829185 A number of factors such as increasing prevalence of infectious diseases in developing countries, rising incidences of lifestyle diseases such as cardiac diseases and diabetes, decreasing number of technicians in central labs, and technological advancements are stimulating the demand for POC testing. Evolution of new POC testing procedures and emerging markets such as China and India represent high growth opportunities for market players. Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=106829185 The market is a diversified and competitive market, with a large number of players. The market (excluding blood glucose monitoring kits market) is dominated by various players, depending on their core competencies. The key players in this market are Roche Diagnostics Ltd. (Switzerland), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.). Whereas, the key players in the global blood glucose monitoring kits market are Roche Diagnostics Limited (Switzerland), Johnson & Johnson (U.S.), Bayer AG (Germany), and Abbott Laboratories (U.S.).
About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.